JP2003507343A5 - - Google Patents

Download PDF

Info

Publication number
JP2003507343A5
JP2003507343A5 JP2001516572A JP2001516572A JP2003507343A5 JP 2003507343 A5 JP2003507343 A5 JP 2003507343A5 JP 2001516572 A JP2001516572 A JP 2001516572A JP 2001516572 A JP2001516572 A JP 2001516572A JP 2003507343 A5 JP2003507343 A5 JP 2003507343A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001516572A
Other languages
Japanese (ja)
Other versions
JP2003507343A (ja
Filing date
Publication date
Priority claimed from GB9919288A external-priority patent/GB2355656B/en
Application filed filed Critical
Publication of JP2003507343A publication Critical patent/JP2003507343A/ja
Publication of JP2003507343A5 publication Critical patent/JP2003507343A5/ja
Pending legal-status Critical Current

Links

JP2001516572A 1999-08-17 2000-08-17 経口及び局所投与用の医薬組成物 Pending JP2003507343A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9919288.2 1999-08-17
GB9919288A GB2355656B (en) 1999-08-17 1999-08-17 Pharmaceutical compositions for oral and topical administration
PCT/GB2000/003161 WO2001012229A1 (en) 1999-08-17 2000-08-17 Pharmaceutical compositions for oral and topical administration

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2004106963A Division JP2004238399A (ja) 1999-08-17 2004-03-31 経口及び局所投与用の医薬組成物

Publications (2)

Publication Number Publication Date
JP2003507343A JP2003507343A (ja) 2003-02-25
JP2003507343A5 true JP2003507343A5 (enExample) 2005-11-17

Family

ID=10859192

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2001516572A Pending JP2003507343A (ja) 1999-08-17 2000-08-17 経口及び局所投与用の医薬組成物
JP2004106963A Pending JP2004238399A (ja) 1999-08-17 2004-03-31 経口及び局所投与用の医薬組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2004106963A Pending JP2004238399A (ja) 1999-08-17 2004-03-31 経口及び局所投与用の医薬組成物

Country Status (40)

Country Link
US (1) US20070190132A1 (enExample)
EP (2) EP1210119B1 (enExample)
JP (2) JP2003507343A (enExample)
KR (2) KR100828748B1 (enExample)
CN (2) CN101406453A (enExample)
AR (2) AR025324A1 (enExample)
AT (2) ATE288766T1 (enExample)
AU (1) AU777740B2 (enExample)
BR (1) BR0013385A (enExample)
CA (2) CA2452118A1 (enExample)
CO (1) CO5380014A1 (enExample)
CY (1) CY1105318T1 (enExample)
CZ (2) CZ296170B6 (enExample)
DE (2) DE60018081T2 (enExample)
DK (2) DK1334717T3 (enExample)
EE (2) EE04954B1 (enExample)
EG (1) EG23994A (enExample)
ES (2) ES2311077T3 (enExample)
GB (1) GB2355656B (enExample)
HK (1) HK1049629A1 (enExample)
HR (1) HRP20020154B1 (enExample)
HU (1) HUP0203236A3 (enExample)
IL (4) IL148200A0 (enExample)
JO (1) JO2324B1 (enExample)
MX (1) MXPA02001631A (enExample)
NO (2) NO20020760L (enExample)
NZ (1) NZ517271A (enExample)
PE (1) PE20010636A1 (enExample)
PL (1) PL192769B1 (enExample)
PT (2) PT1210119E (enExample)
RU (2) RU2279894C2 (enExample)
SA (1) SA00210487B1 (enExample)
SG (1) SG143019A1 (enExample)
SI (1) SI1210119T1 (enExample)
SK (2) SK286083B6 (enExample)
TN (1) TNSN00173A1 (enExample)
UA (2) UA72539C2 (enExample)
UY (1) UY26303A1 (enExample)
WO (1) WO2001012229A1 (enExample)
ZA (2) ZA200308221B (enExample)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration
FR2826261B1 (fr) * 2001-06-26 2005-03-25 Lmd Composition a usage topique comprenant un produit cytotoxique et son utilisation dans le traitement de l'alopeche
DE10154464B4 (de) * 2001-11-08 2005-10-20 Max Delbrueck Centrum Oral verabreichbare pharmazeutische Zubereitung umfassend liposomal verkapseltes Taxol
KR20030065831A (ko) * 2002-02-01 2003-08-09 주식회사 태평양 사이클로스포린을 함유한 지속 방출형 약학적 조성물
US7101576B2 (en) 2002-04-12 2006-09-05 Elan Pharma International Limited Nanoparticulate megestrol formulations
US9101540B2 (en) 2002-04-12 2015-08-11 Alkermes Pharma Ireland Limited Nanoparticulate megestrol formulations
EP1935407A1 (en) * 2002-12-03 2008-06-25 Elan Pharma International Limited Low viscosity liquid dosage forms
JP4518042B2 (ja) * 2002-12-04 2010-08-04 日油株式会社 コエンザイムq10を含有する水溶性組成物の製造方法
WO2004050072A1 (ja) * 2002-12-04 2004-06-17 Nisshin Pharma Inc. コエンザイムq10を含有する水溶性組成物
EP2359859A1 (en) * 2002-12-09 2011-08-24 Abraxis BioScience, LLC Compositions comprising albumin nanoparticles and methods of delivery of pharmacological agents
US6979672B2 (en) 2002-12-20 2005-12-27 Polichem, S.A. Cyclosporin-based pharmaceutical compositions
TW200616681A (en) * 2004-10-05 2006-06-01 Recordati Ireland Ltd Lercanidipine capsules
WO2006043621A1 (ja) * 2004-10-20 2006-04-27 Kao Corporation 液体口腔用組成物
MX2007010394A (es) * 2005-02-24 2008-02-19 Elan Pharma Int Ltd Formulaciones nanoparticuladas de docetaxel y analogos del mismo.
CN102227211A (zh) * 2008-11-28 2011-10-26 先进控股有限公司 包含双氯芬酸和羟基脂肪酸聚氧化烯烃酯的药物配制剂
PL2405892T3 (pl) * 2009-03-12 2013-10-31 Lectio Pharmaentwicklungs Und Verwertungs Gmbh Preparat farmaceutyczny zawierający ketoprofen i ester polioksyalkilenowy kwasu hydroksytłuszczowego
KR101100933B1 (ko) * 2009-04-23 2012-01-02 한국기술교육대학교 산학협력단 솔더 볼 제거 장치
WO2016160412A1 (en) * 2015-03-27 2016-10-06 Arch Personal Care Products, Lp Viscosity building composition for personal care products
CN112426403B (zh) * 2020-12-09 2021-09-17 南京天纵易康生物科技股份有限公司 一种口腔溃疡凝胶及其制备方法和应用
TW202406566A (zh) * 2022-05-02 2024-02-16 日商中外製藥股份有限公司 包含用於與界面活性劑結合使用之胜肽化合物的組合物
CN119770478B (zh) * 2024-12-31 2025-12-19 美济生物医药(广州)有限公司 紫杉醇口服药物组合物、制剂及其制备方法和应用

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2222770B (en) * 1988-09-16 1992-07-29 Sandoz Ltd Pharmaceutical compositions containing cyclosporins
US5342625A (en) * 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
US6007840A (en) * 1988-09-16 1999-12-28 Novartis Ag Pharmaceutical compositions comprising cyclosporins
CZ288631B6 (cs) * 1996-01-18 2001-08-15 Galena, A. S. Léčivé přípravky s obsahem cyklosporinu
CZ288739B6 (cs) * 1996-08-01 2001-08-15 Galena, A. S. Cyklosporin obsahující léčivé přípravky
CZ283516B6 (cs) * 1996-09-12 1998-04-15 Galena A.S. Léčivé přípravky, zejména pro vnitřní aplikaci, ve formě samomikroemulgujících terapeutických systémů
SI0969856T1 (en) * 1997-03-12 2005-06-30 Abbott Laboratories Hydrophilic binary systems for the administration of cyclosporine
WO1998040051A1 (en) * 1997-03-12 1998-09-17 Abbott Laboratories Lipophilic binary systems for the administration of lipophilic compounds
CA2294031E (en) * 1997-07-29 2012-04-03 Pharmacia & Upjohn Company Self-emulsifying formulation for lipophilic compounds
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
US20030216303A1 (en) * 1998-03-06 2003-11-20 Michael Ambuhl Emulsion preconcentrates containing cyclosporin or a macrolide
GB2355656B (en) * 1999-08-17 2004-04-07 Galena As Pharmaceutical compositions for oral and topical administration

Similar Documents

Publication Publication Date Title
BE2015C062I2 (enExample)
BE2014C009I2 (enExample)
BE2013C048I2 (enExample)
BE2011C032I2 (enExample)
BRPI0113420B8 (enExample)
BRPI0112928B8 (enExample)
JP2002177481A5 (enExample)
BRPI0113372A8 (enExample)
JP2001330976A5 (enExample)
BRPI0003419A (enExample)
CN3141006S (enExample)
CN3141410S (enExample)
AU2000278679A8 (enExample)
AU2000274567A8 (enExample)
AU2000256911A8 (enExample)
AU2000240338A8 (enExample)
BY4905C1 (enExample)
CN3135921S (enExample)
CN3137256S (enExample)
CN3137472S (enExample)
CN3137601S (enExample)
CN3138983S (enExample)
CN3139851S (enExample)
CN3139997S (enExample)
AU2000239526A8 (enExample)